APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 50 filers reported holding APTEVO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $37,000 | -37.3% | 56,181 | -44.2% | 0.00% | – |
| Q3 2019 | $59,000 | +18.0% | 100,640 | +77.7% | 0.00% | – |
| Q2 2019 | $50,000 | +257.1% | 56,620 | +256.3% | 0.00% | – |
| Q1 2019 | $14,000 | -41.7% | 15,892 | -15.4% | 0.00% | – |
| Q4 2018 | $24,000 | -75.0% | 18,777 | -0.4% | 0.00% | – |
| Q3 2018 | $96,000 | +1.1% | 18,852 | -0.9% | 0.00% | – |
| Q2 2018 | $95,000 | +33.8% | 19,022 | -12.3% | 0.00% | – |
| Q1 2018 | $71,000 | -12.3% | 21,692 | +12.4% | 0.00% | – |
| Q4 2017 | $81,000 | +84.1% | 19,297 | -0.5% | 0.00% | – |
| Q3 2017 | $44,000 | +10.0% | 19,402 | 0.0% | 0.00% | – |
| Q2 2017 | $40,000 | -68.0% | 19,402 | -68.2% | 0.00% | – |
| Q1 2017 | $125,000 | -64.7% | 60,995 | -58.0% | 0.00% | – |
| Q4 2016 | $354,000 | -11.5% | 145,327 | -7.1% | 0.00% | – |
| Q3 2016 | $400,000 | – | 156,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HighVista Strategies LLC | 196,600 | $981,000 | 0.44% |
| Sessa Capital IM, L.P. | 519,894 | $2,594,000 | 0.26% |
| Alambic Investment Management, L.P. | 116,427 | $581,000 | 0.16% |
| Park West Asset Management LLC | 500,000 | $2,495,000 | 0.09% |
| EAM Investors, LLC | 110,584 | $552,000 | 0.09% |
| ATLAS CAPITAL ADVISORS LLC | 49,045 | $232,473,000 | 0.08% |
| Spark Investment Management LLC | 135,600 | $676,000 | 0.04% |
| CSS LLC/IL | 118,736 | $592,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 172,639 | $874,000 | 0.02% |
| SFMG, LLC | 15,544 | $78,000 | 0.01% |